Hematologia Oncologia San Pablo
About Hematologia Oncologia San Pablo
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
4
SWOG Cancer Research Network
3
Alliance for Clinical Trials in Oncology
2
ECOG-ACRIN Cancer Research Group
2
Clinical Trials at Hematologia Oncologia San Pablo
During the past decade, Hematologia Oncologia San Pablo conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on
average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
2013-12-02
2034-02-05
Active, not recruiting
1,087
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
2016-07-07
2023-10-31
Active, not recruiting
333
Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
2017-05-12
2023-06-30
Active, not recruiting
444
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
2017-09-12
2024-04-02
Active, not recruiting
700
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
2016-12-08
2023-02-15
Terminated
3,021
Simplified Patient Care Strategy in Decreasing Early Death in Patients With Acute Promyelocytic Leukemia
2017-08-16
2025-08-18
Active, not recruiting
202
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
2017-10-09
2024-06-15
Active, not recruiting
240
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hematologia Oncologia San Pablo"
#1 collaborator was "National Cancer Institute (NCI)" with 7 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Division of Cancer Control" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 7 trials.
Clinical Trials Conditions at Hematologia Oncologia San Pablo
According to Clinical.Site data, the most researched conditions in "Hematologia Oncologia San Pablo" are
"Colon Adenocarcinoma" (2 trials), "Metastatic Malignant Neoplasm in the Brain" (2 trials), "Recurrent Breast Carcinoma" (2 trials), "Recurrent Ovarian Carcinoma" (2 trials) and "Stage IV Breast Cancer AJCC v6 and v7" (2 trials). Many other conditions were trialed in "Hematologia Oncologia San Pablo" in a lesser frequency.
Clinical Trials Intervention Types at Hematologia Oncologia San Pablo
Most popular intervention types in "Hematologia Oncologia San Pablo" are "Other" (10 trials), "Drug" (8 trials), "Biological" (3 trials), "Procedure" (3 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (5 trials), "Quality-of-Life Assessment" (4 trials), "Atezolizumab" (2 trials), "Computed Tomography" (2 trials) and "Anxiety Questionnaire Administration" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hematologia Oncologia San Pablo
The vast majority of trials in "Hematologia Oncologia San Pablo" are
8 trials for "All" genders and 3 trials for "Female" genders.
Clinical Trials Status at Hematologia Oncologia San Pablo
Currently, there are NaN active trials in "Hematologia Oncologia San Pablo".
undefined are not yet recruiting,
2 are recruiting,
8 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Hematologia Oncologia San Pablo,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Hematologia Oncologia San Pablo, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".